These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 16473115)
41. The safety of statins in children. Lamaida N; Capuano E; Pinto L; Capuano E; Capuano R; Capuano V Acta Paediatr; 2013 Sep; 102(9):857-62. PubMed ID: 23631461 [TBL] [Abstract][Full Text] [Related]
42. Updated guidelines support even lower cholesterol levels for at-risk patients. Levenson D Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342 [No Abstract] [Full Text] [Related]
43. [Lower, lower, lower. The LDL goal value of 200 mg/dl is still much too high]. Einecke D MMW Fortschr Med; 2004 Mar; 146(13):4-5. PubMed ID: 15219114 [No Abstract] [Full Text] [Related]
47. Clinical inquiries. What is the target for low-density lipoprotein cholesterol in patients with heart disease? Stevermer JJ; Meadows SE J Fam Pract; 2002 Oct; 51(10):893. PubMed ID: 12401164 [No Abstract] [Full Text] [Related]
48. Means and ends of statins and low-density lipoprotein cholesterol lowering. LaRosa JC J Am Coll Cardiol; 2007 Jul; 50(5):419-20. PubMed ID: 17662393 [No Abstract] [Full Text] [Related]
49. Comparative efficacy and safety of low-dose pitavastatin versus atorvastatin in patients with hypercholesterolemia. Sansanayudh N; Wongwiwatthananukit S; Putwai P; Dhumma-Upakorn R Ann Pharmacother; 2010 Mar; 44(3):415-23. PubMed ID: 20179259 [TBL] [Abstract][Full Text] [Related]
50. Lipid management with statins. The lower the better? Laufs U; Liao JK; Böhm M Z Kardiol; 2004 Jan; 93(1):4-9. PubMed ID: 14740235 [TBL] [Abstract][Full Text] [Related]
51. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Raggi P; Davidson M; Callister TQ; Welty FK; Bachmann GA; Hecht H; Rumberger JA Circulation; 2005 Jul; 112(4):563-71. PubMed ID: 16009795 [TBL] [Abstract][Full Text] [Related]
52. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1329-30. PubMed ID: 15297284 [No Abstract] [Full Text] [Related]
53. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption. Bruckert E; Giral P; Tellier P Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406 [No Abstract] [Full Text] [Related]
54. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins. Barter PJ; Rye KA Circulation; 2006 Sep; 114(12):1315-20; discussion 1320. PubMed ID: 16982953 [No Abstract] [Full Text] [Related]